Difference between revisions of "Part:BBa K1469009"
(→Improvement) |
|||
Line 18: | Line 18: | ||
<!-- --> | <!-- --> | ||
+ | |||
+ | =====Improvement===== | ||
<html> | <html> | ||
<body> | <body> | ||
− | |||
Improvement Team:<h4>2018 SSTi-SZGD</h4> | Improvement Team:<h4>2018 SSTi-SZGD</h4> | ||
− | |||
<h4>Usage</h4> | <h4>Usage</h4> | ||
<P> | <P> |
Revision as of 14:24, 17 October 2018
gcaD
UDP-N-acetylglucosamine pyrophosphorylase of Bacillus megaterium. The enzyme is bifunctional and catalyses the conversion of glucosamine 1-phosphate to N-acetyl glucosamine 1-phosphate as well as the conversion of N-acetyl glucosamine 1-phosphate to UDP-N-acetyl glucosamine, a key precursor molecule for hyaluronic acid production.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21INCOMPATIBLE WITH RFC[21]Illegal BamHI site found at 768
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI.rc site found at 220
Improvement
Improvement Team:
2018 SSTi-SZGD
Usage
This is a improvement part of glmU (2014 saarland iGEM team) (also known as : GcaD in B.megaterium)
This device is used to over-express glmU gene in B. subtilis 168. glmU encodes UDP-N-acetylglucosamine pyrophosphorylase that converts GlcN-1-P to GlcNAc-1-P as well as GlcNAc-1-P to UDP-GlcNAc in the synthetic pathway of UDP-GlcNAc, one of the two HA precursors in B. subtilis. It is assumed that overexpression of glmU contributes to the elevation of UDP-GlcNAc production, which may have a positive effect on HA production.
In our project, glmU expression was regulated under the control of a constitutive promoter P43, and the recombinant pP43NMK-glmU vector was transformed into recombinant B.subtilis 168E, confirmed by colony PCR polymerization(Fig2) . It has been engineered to secrete extracellular HA. Our results showed the introduction of extra copies of glmU gene, resulted to an elevated HA accumulation in B.subtilis 168E (448mg/L, a 32% increase) (Fig3). Molecular weight analysis studies showed that HAs synthesized were high molecular weight(Fig4).
In our project, glmU expression was regulated under the control of a constitutive promoter P43, and the recombinant pP43NMK-glmU vector was transformed into recombinant B.subtilis 168E, confirmed by colony PCR polymerization(Fig2) . It has been engineered to secrete extracellular HA. Our results showed the introduction of extra copies of glmU gene, resulted to an elevated HA accumulation in B.subtilis 168E (448mg/L, a 32% increase) (Fig3). Molecular weight analysis studies showed that HAs synthesized were high molecular weight(Fig4).